eMedicine Specialties > Radiology > Chest

Localized Fibrous Tumor of the Pleura

Author: Moulay Meziane, MD, Head, Section of Thoracic Imaging, Department of Radiology, Cleveland Clinic Foundation
Coauthor(s): Omar Lababede, MD, Consulting Staff, Department of Regional Diagnostic Radiology, Cleveland Clinic Foundation
Contributor Information and Disclosures

Updated: Aug 2, 2007

Introduction

Background

Most pleural neoplasms are metastatic in origin. Primary tumors of the pleura can be categorized as diffuse or localized. Diffuse malignant mesothelioma is more common, related to asbestos exposure, and associated with a poor prognosis. Localized mesothelioma, called localized fibrous tumor of the pleura (LFTP), is a less common neoplasm of controversial histogenesis and is unrelated to asbestos exposure.

LFTPs exist in benign and malignant forms. Only rarely is the localized fibrous tumor invasive or does it cause local recurrence after resection. The ratio of benign to malignant tumors is 7:1. The diagnosis of LFTP is important because the tumor is potentially resectable for cure despite its typically large size. In many cases, resection can repeatedly be used to treat recurrence, although usually with increasing difficulty.1

Pathophysiology

The etiology of LFTPs is unknown. No association exists with smoking or asbestos exposure. Although some studies indicate that LFTPs are mesothelial in origin, other reports suggest that they originate from primitive submesothelial mesenchymal cells that are distinct from diffuse malignant mesothelioma. Histologically, the lesions are usually composed of spindle-shaped cells and variable fibrous stroma. Occasionally, oval or polygonal cells may be present. Areas of myxoid degeneration, hyalinization, necrosis, or hemorrhage can be present, especially with large masses.

The malignant variant of the LFTP has high cellularity and nuclear pleomorphic mitotic activity. Hemorrhage and necrosis are more frequent in the malignant form. Grossly, an LFTP is a firm soft-tissue mass that is usually larger than 5 cm in diameter. The tumor can arise anywhere in the chest along the pleura, although it appears more commonly from the visceral pleura than it does from the parietal pleura. Lesions can arise from the interlobar fissures. The tumor is often attached by a short pedicle. In 1 study, approximately 50% of tumors were found to have pedicles, and 50% were broad based.

Intrapulmonary lesions are reported but are exceedingly rare. LFTPs are solitary in the overwhelming majority of cases; the presence of synchronous lesions is extremely rare.

Frequency

United States

LFTP is a rare disease.

Mortality/Morbidity

Resectability has been shown to be the single most important determinant of the patient's clinical outcome.

Race

No racial predilection has been described.

Sex

Males and females are affected in almost equal numbers.

Age

LFTPs can affect all age groups, but they are most often seen in people who are in their sixth or seventh decade.

Presentation

Most patients are asymptomatic, and the lesion is discovered incidentally on chest radiographs. When present, symptoms are usually related to the local mass effect of large lesions or to the associated paraneoplastic phenomena. Symptomatic patients may report dyspnea, cough, or vague chest or shoulder discomfort.

Paraneoplastic manifestations have been reported in LFTP, including hypertrophic pulmonary osteoarthropathy and hypoglycemia. Hypertrophic pulmonary osteoarthropathy was reported in 4-35% of patients in some series, and it was found to be associated with LFTP more frequently than with lung cancer. Hypoglycemia has been less frequently associated with LFTP; it has been reported in 5% of patients and could be related to insulinlike growth factor type 2 [IGF-2].

The tumor may become large, occupying much of the hemithorax.

Preferred Examination

Usually, LFTP is incidentally discovered on chest radiographs. Findings from computed tomography (CT) scanning and magnetic resonance imaging (MRI) can suggest the diagnosis of LFTP. However, histopathologic examination is needed for a definitive diagnosis.

Limitations of Techniques

Chest radiographic findings are nonspecific, and the lesion can sometimes be obscured by associated pleural effusion. CT scans and magnetic resonance images may show characteristic findings that are suggestive of LFTP but that are not always pathognomonic. The pleural origin of large lesions can be difficult to detect, especially on chest radiographs and even on CT scans and magnetic resonance images.

Differential Diagnoses

Lung Cancer, Non-Small Cell
Mesothelioma, Malignant

Other Problems to Be Considered

Sarcoma
Elevated hemidiaphragm
Loculated pleural effusion
Pleural metastases
Pleural desmoid

More on Localized Fibrous Tumor of the Pleura

Overview: Localized Fibrous Tumor of the Pleura
Imaging: Localized Fibrous Tumor of the Pleura
Follow-up: Localized Fibrous Tumor of the Pleura
Multimedia: Localized Fibrous Tumor of the Pleura
References

References

  1. Mahesh B, Clelland C, Ratnatunga C. Recurrent localized fibrous tumor of the pleura. Ann Thorac Surg. Jul 2006;82(1):342-5. [Medline].

  2. Hara M, Kume M, Oshima H, et al. F-18 FDG uptake in a malignant localized fibrous tumor of the pleura. J Thorac Imaging. May 2005;20(2):118-9. [Medline].

  3. Ordóñez NG. Localized (solitary) fibrous tumor of the pleura. Adv Anat Pathol. Nov 2000;7(6):327-40. [Medline].

  4. Altinok T, Topçu S, Tastepe AI, et al. Localized fibrous tumors of the pleura: clinical and surgical evaluation. Ann Thorac Surg. Sep 2003;76(3):892-5. [Medline].

  5. Cole FH Jr, Ellis RA, Goodman RC, et al. Benign fibrous pleural tumor with elevation of insulin-like growth factor and hypoglycemia. South Med J. Jun 1990;83(6):690-4. [Medline].

  6. Desser TS, Stark P. Pictorial essay: solitary fibrous tumor of the pleura. J Thorac Imaging. Jan 1998;13(1):27-35. [Medline].

  7. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol. Aug 1989;13(8):640-58. [Medline].

  8. Ferretti GR, Chiles C, Choplin RH, et al. Localized benign fibrous tumors of the pleura. AJR Am J Roentgenol. Sep 1997;169(3):683-6. [Medline].

  9. Ferretti GR, Chiles C, Cox JE, et al. Localized benign fibrous tumors of the pleura: MR appearance. J Comput Assist Tomogr. Jan-Feb 1997;21(1):115-20. [Medline].

  10. Harris GN, Rozenshtein A, Schiff MJ. Benign fibrous mesothelioma of the pleura: MR imaging findings. AJR Am J Roentgenol. Nov 1995;165(5):1143-4. [Medline].

  11. Lee KS, Im JG, Choe KO, et al. CT findings in benign fibrous mesothelioma of the pleura: pathologic correlation in nine patients. AJR Am J Roentgenol. May 1992;158(5):983-6. [Medline].

  12. Mendelson DS, Meary E, Buy JN, et al. Localized fibrous pleural mesothelioma: CT findings. Clin Imaging. Apr-Jun 1991;15(2):105-8. [Medline].

  13. Rosado-de-Christenson ML, Abbott GF, McAdams HP, et al. From the archives of the AFIP: Localized fibrous tumor of the pleura. Radiographics. May-Jun 2003;23(3):759-83. [Medline].

  14. Tatepe I, Alper A, Ozaydin HE, et al. A case of multiple synchronous localized fibrous tumor of the pleura. Eur J Cardiothorac Surg. Oct 2000;18(4):491-4. [Medline].

  15. Veronesi G, Spaggiari L, Mazzarol G, et al. Huge malignant localized fibrous tumor of the pleura. J Cardiovasc Surg (Torino). Oct 2000;41(5):781-4. [Medline].

  16. Wilson RW, Gallateau-Salle F, Moran CA. Desmoid tumors of the pleura: a clinicopathologic mimic of localized fibrous tumor. Mod Pathol. Jan 1999;12(1):9-14. [Medline].

Further Reading

Keywords

LFTP, benign mesothelioma, fibrous mesothelioma, localized mesothelioma, diffuse mesothelioma, malignant mesothelioma, subpleural fibroma, submesothelial fibroma, pleural fibroma, pleural fibromyxoma, solitary fibrous tumor, localized fibrous pleural tumor, lung tumor, pleural tumor, pleural neoplasm, lung cancer, diffuse pleural tumor, localized pleural tumor

Contributor Information and Disclosures

Author

Moulay Meziane, MD, Head, Section of Thoracic Imaging, Department of Radiology, Cleveland Clinic Foundation
Moulay Meziane, MD is a member of the following medical societies: Radiological Society of North America
Disclosure: Nothing to disclose.

Coauthor(s)

Omar Lababede, MD, Consulting Staff, Department of Regional Diagnostic Radiology, Cleveland Clinic Foundation
Omar Lababede, MD is a member of the following medical societies: American College of Radiology and Radiological Society of North America
Disclosure: Nothing to disclose.

Medical Editor

Kitt Shaffer, MD, PhD, Director of Undergraduate Medical Education, Associate Professor, Department of Radiology, Cambridge Health Alliance
Kitt Shaffer, MD, PhD is a member of the following medical societies: American Roentgen Ray Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

W Richard Webb, MD, Chief of Thoracic Imaging, Professor, Department of Radiology, University of California at San Francisco
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Eugene C Lin, MD, Consulting Staff, Department of Radiology, Virginia Mason Medical Center
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, and Society of Nuclear Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.